go-v.orgdoi

Biomarkers of corticosteroid-induced hypertrophic cardiomyopathy in preterm babies

Pier Paolo Bassareo, Raul Abella, Vassilios Fanos, GIUSEPPE MERCURO · Frontiers in Bioscience-Elite · 2010

  • DOI 10.2741/e205
  • Publisher Frontiers Media
  • Type article
  • Issued 2010

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Frontiers in Bioscience-Elite · Frontiers Media · article · 2010

Abstract

The study of biomarkers and their signaling pathways has led to the development of new therapeutic strategies in a number of disorders. The purpose of the present systematic review is to provide an overview of different biomarkers in preterm newborns with corticosteroid-induced hypertrophic cardiomyopathy (CCHC). Several pathophysiological biomarkers are presented and discussed with the aim of investigating their diagnostic and prognostic value, particularly in relation to the potential progression of the disease and/or mortality in adulthood.

This investigative approach may not only provide pathophysiological information on this serious drug-induced adverse effect, but also suggest novel therapeutic approaches to be applied in controlling its harmful consequences.

Open the resolved locator · 10.2741/e205

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:53 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.2741/e205
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.